These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34312424)

  • 1. Impact of anticoagulation and antiplatelet drugs on surgery rates and mortality in trauma patients.
    Bläsius FM; Laubach M; Andruszkow H; Lübke C; Lichte P; Lefering R; Hildebrand F; Horst K
    Sci Rep; 2021 Jul; 11(1):15172. PubMed ID: 34312424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of mortality among trauma patients taking preinjury direct oral anticoagulants versus vitamin K antagonists.
    LaDuke ZJ; Hecht JP; Cain-Nielsen AH; Hemmila MR; Wahl WL
    Surgery; 2019 Oct; 166(4):564-571. PubMed ID: 31439398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct oral anticoagulants and cardiac surgery: A descriptive study of preoperative management and postoperative outcomes.
    Fox V; Kleikamp A; Dittrich M; Zittermann A; Flieder T; Knabbe C; Gummert J; Birschmann I
    J Thorac Cardiovasc Surg; 2021 May; 161(5):1864-1874.e2. PubMed ID: 31982117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of direct oral anticoagulant and vitamin K antagonists on outcomes among elderly and nonelderly trauma patients.
    Nishimura T; Guyette FX; Naito H; Nakao A; Brown JB; Callaway CW
    J Trauma Acute Care Surg; 2020 Sep; 89(3):514-522. PubMed ID: 32544105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of older hip fracture patients on anticoagulation: a comparison of vitamin K-antagonists and Factor Xa inhibitors.
    Gosch M; Jacobs M; Bail H; Grueninger S; Wicklein S
    Arch Orthop Trauma Surg; 2021 Apr; 141(4):637-643. PubMed ID: 32710342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
    Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG;
    Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair.
    Paparella D; Di Mauro M; Bitton Worms K; Bolotin G; Russo C; Trunfio S; Scrofani R; Antona C; Actis Dato G; Casabona R; Colli A; Gerosa G; Renzulli A; Serraino F; Scrascia G; Zaccaria S; De Bonis M; Taramasso M; Delgado L; Tritto F; Marmo J; Parolari A; Myaseodova V; Villa E; Troise G; Nicolini F; Gherli T; Whitlock R; Conte M; Barili F; Gelsomino S; Lorusso R; Sciatti E; Marinelli D; Di Giammarco G; Calafiore AM; Sheikh A; Alfonso JJ; Glauber M; Miceli A;
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1302-8.e1. PubMed ID: 26832208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
    Alexander JH; Wojdyla D; Vora AN; Thomas L; Granger CB; Goodman SG; Aronson R; Windecker S; Mehran R; Lopes RD
    Circulation; 2020 May; 141(20):1618-1627. PubMed ID: 32223444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.
    Mai V; Bertoletti L; Cucherat M; Jardel S; Grange C; Provencher S; Lega JC
    PLoS One; 2019; 14(4):e0214134. PubMed ID: 30933993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with non-valvular atrial fibrillation on vitamin k antagonists or direct-acting oral anticoagulants: patients profile and long-term follow up outcomes.
    Sigismondi A; Camacho-Freire SJ; León-Jiménez J; Isasti-Aizpurva G; García-Lizana MD; Morgado-García de Polavieja JI; Caro-Fernández FJ; Roa-Garrido J; Navarro-Roldán F; Díaz-Fernández JF
    Arch Cardiol Mex; 2019; 89(4):382-392. PubMed ID: 31834326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
    Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
    JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation].
    Saliba L; Mondoly P; Duparc A; Bura-Rivière A; Maury P; Calmels V; Sallerin B; Pathak A; Montastruc JL; Bagheri H
    Therapie; 2015; 70(6):485-92. PubMed ID: 26223162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of oral anticoagulation on proximal femur fractures treated within 24 h - A retrospective chart review.
    Schuetze K; Eickhoff A; Dehner C; Gebhard F; Richter PH
    Injury; 2019 Nov; 50(11):2040-2044. PubMed ID: 31543315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant-related gastrointestinal bleeding: a real-life data analysis on bleeding profiles, frequency and etiology of patients receiving direct oral anticoagulants versus vitamin K antagonists.
    Albrecht H; Maass LS; Hagel AF; Neurath MF; Konturek PC; Raithel M
    J Physiol Pharmacol; 2019 Dec; 70(6):. PubMed ID: 32203937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Oral Anticoagulant Treatment and Mild Traumatic Brain Injury: Risk of Early and Delayed Bleeding and the Severity of Injuries Compared with Vitamin K Antagonists.
    Turcato G; Zannoni M; Zaboli A; Zorzi E; Ricci G; Pfeifer N; Maccagnani A; Tenci A; Bonora A
    J Emerg Med; 2019 Dec; 57(6):817-824. PubMed ID: 31648805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs.
    Pannach S; Goetze J; Marten S; Schreier T; Tittl L; Beyer-Westendorf J
    J Gastroenterol; 2017 Dec; 52(12):1211-1220. PubMed ID: 28210867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis.
    Rossel A; Robert-Ebadi H; Combescure C; Grosgurin O; Stirnemann J; Addeo A; Garin N; Agoritsas T; Reny JL; Marti C
    PLoS One; 2019; 14(3):e0213940. PubMed ID: 30897142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation versus antiplatelet or no therapy in patients undergoing bioprosthetic valve implantation: a systematic review and meta-analysis.
    Masri A; Gillinov AM; Johnston DM; Sabik JF; Svensson LG; Rodriguez LL; Kapadia SR; Stewart WJ; Grimm RA; Griffin BP; Desai MY
    Heart; 2017 Jan; 103(1):40-48. PubMed ID: 27487810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.